We have crossed 150 peeps so on to a second starter pack
https://t.co/uS0bEmonle
Join now and ping me to get added and dive into the #NephSky community rightaway
1/10
Did you miss last week’s #NephJC chat?
Too busy fretting over politics?
No worries, the #TenTweetNephJC will get you all caught-up on Long-term Effects of #Empagliflozin in patients with #CKD
10/10
Final #nephjc thoughts
✳️ The 🔑 takeaway from this study is straightforward 👉 initiate #SGLT2i early, ensure consistent therapy, & recognize that the protective effects are not sustained after discontinuation.
Flozinate early and persist with flozination.
Monotypic fibrillary glomerulonephritis is not a MGRS in the vast majority of cases.
In cases with monotypic fibrillary - do IgG subclasses, do par IF, and check SPEP/UPEP for evaluation of true clonality.
Insights from @VBijol and @MayoClinicPath at @GlomCon
Holy shit this is INCREDIBLE work from @ByDonkeys. And bonus points for projecting the entire thing on @Tesla headquarters, effectively turning @elonmusk’s building’s most visible exterior side into a cinema screen to broadcast the tale of his corruption and political malfeasance
Now open access in @NDTsocial@fervenzafernan1@fcaravacafontan
Hydroxychloroquine for all patients with lupus nephritis: No!
🧐"In an era of modern immunosuppression ... HCQ for all no longer makes sense"
"Yes" part will come in @NDTsocial soon
▶️https://t.co/VAxA698EjW
@hswapnil@NephroSeeker Can’t help but think that #flozination is not a skill but an attitude.
I don’t think there will be a better word. And thanks to #nephjc et al for bringing it into existence.
Interesting viewpoint from @jingelfinger
Way Stations in Progress — Burgeoning Treatment Options for IgA Nephropathy | New England Journal of Medicine https://t.co/04X2Dqky4v
@NephroSeeker#NephJC proteinuria is a surrogate of a surrogate (eg. eGFR decline) which is itself a surrogate of clinical kidney failure…& there is no surrogate for safety. Our community must prioritise large trials wherever we can…our patients deserve better!
We are delighted to announce the full programme for our online conference taking place next week November 6th: Rare Rheumatology, Niche Conditions and Future Directions. Registration is still open via the link below:
https://t.co/PldLz3rf97
@Tiff_Caza@dakidneydoc@NephroSeeker Agree 💯. It is easy to see her beautiful visual abstracts and passion for nephrology. @NephroSeeker is also an incredibly kind and warm hearted person. Superstar.